Aerovate Therapeutics, INC. (JBIO) — SC 13D/A Filings
All SC 13D/A filings from Aerovate Therapeutics, INC.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
RA Capital Amends Stake in Aerovate Therapeutics
— Jun 20, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and Ra Capital Healthcare Fund, L.P., have amended their Schedule 13D filing concerni -
RA Capital Amends Aerovate Therapeutics Stake
— Apr 30, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have amended their Schedule 13D filing for Aero -
Sofinnova Amends Aerovate Therapeutics Stake
— Feb 20, 2024 Risk: low
Sofinnova Venture Partners X, L.P. filed an Amendment No. 2 to their Schedule 13D on February 20, 2024, regarding their ownership in Aerovate Therapeutics, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX